Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

341.158 - 365.129 Dr. Andrea Apolo

So great question. And that was one of the things that I really liked about this trial was that it was very practical and real world. And that's what I do in the real world is I go down to 40 and I split the dose. If I can make a patient cis-platinum eligible, I do. And whatever I can do to help the patient become platinum eligible is very important to me, cis-platinum eligible specifically.